Saitama, Japan

Kunio Kobayashi

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Misato, JP (2015 - 2019)
  • Saitama, JP (2000 - 2022)

Company Filing History:


Years Active: 2000-2024

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations by Inventor Kunio Kobayashi

Introduction

Kunio Kobayashi is a prominent inventor based in Saitama, Japan, renowned for his contributions to pharmaceutical research and development. With a total of 14 patents to his name, he has significantly impacted the fields of medicinal chemistry and therapeutic innovations.

Latest Patents

Among his latest inventions is the P2X4 receptor antagonist, a complex diazepine derivative designed to provide therapeutic benefits. The chemistry of this compound involves intricate variations where components like hydrogen atoms, benzene rings, and various atomic bonds play crucial roles in its functionality. The detailed formula indicates the potential for significant medical applications, highlighting Kobayashi's expertise in creating valuable pharmaceutical agents.

Career Highlights

Kobayashi has worked with notable organizations including Nippon Chemiphar Co., Ltd. and Kyushu University. His roles at these institutions have allowed him to leverage his expertise in drug development and contribute to groundbreaking discoveries in the pharmaceutical sector.

Collaborations

Throughout his career, Kunio Kobayashi has collaborated with esteemed colleagues such as Shogo Sakuma and Toshiyasu Imai. These partnerships have fostered a collaborative environment that stimulates innovation and problem-solving in the challenges faced by the pharmaceutical industry.

Conclusion

In conclusion, Kunio Kobayashi's contributions as an inventor are marked by his prolific patent portfolio and impactful collaborations. His work is pivotal in advancing therapeutic applications, showcasing the essential role of innovation in transforming health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…